Nu-MedLogo.jpg
Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device
July 28, 2020 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Nu-MedLogo.jpg
Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
June 18, 2019 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the...
Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
February 05, 2019 05:30 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit...
Nu-MedLogo.jpg
Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry
December 04, 2018 08:00 ET | Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, released an open letter from Nu-Med Plus...
Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent
November 14, 2018 12:07 ET | Nu-Med Plus Inc.
Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions SALT LAKE CITY, Nov. 14, 2018 (GLOBE NEWSWIRE) --...